All posts in
What are the Current Challenges in the Booming Field of ADCs?
In the Age of Biological Therapeutics, Chemists move to ADCs
New Immunotherapy Candidate receives FDA Fast Track Designation
The English Countryside brings Innovation in Immuno-Oncology
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
Advancing Leukemia Treatments from the Heart of Paris
Cannabinoid Drug Prolongs the Life of Brain Tumor Patients in Phase II Trials
British Synbio’s Llama Antibodies recruited for Cancer T-Cell Therapy
UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy gets ready for Clinical Trials
Better and Safer Bone Marrow Transplants for Leukemia enter Phase III
French Biotech’s Checkpoint Inhibitor Fails Phase II Leukemia Trial
World Cancer Day is Saturday! Europe’s Oncology in Numbers
Labiotech UG, All Rights Reserved -
Send this to friend